JAVIER
RUIZ MARTINEZ
PROFESORADO AGREGADO
Universitat de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadoras/es de Universitat de Barcelona (13)
2023
-
Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson’s disease
npj Parkinson's Disease, Vol. 9, Núm. 1
-
Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort
Movement Disorders, Vol. 38, Núm. 2, pp. 286-303
2021
-
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils
Acta Neuropathologica, Vol. 142, Núm. 3, pp. 475-494
2020
-
Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance
Movement Disorders, Vol. 35, Núm. 10, pp. 1755-1764
2019
-
Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls
Movement Disorders, Vol. 34, Núm. 9, pp. 1392-1398
-
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344
2017
-
Inflammatory profile discriminates clinical subtypes in LRRK2-associated Parkinson's disease
European Journal of Neurology, Vol. 24, Núm. 2, pp. 427-e6
-
Penetrance estimate of LRRK2 p.G2019S mutation in individuals of non-Ashkenazi Jewish ancestry
Movement Disorders, Vol. 32, Núm. 10, pp. 1432-1438
2016
-
Inflammatory profile in LRRK2-associated prodromal and clinical PD
Journal of Neuroinflammation, Vol. 13, Núm. 1
-
Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson's disease
Movement Disorders, Vol. 31, Núm. 8, pp. 1192-1202
2015
-
Clinical correlations with lewy body pathology in LRRK2-related Parkinson disease
JAMA Neurology, Vol. 72, Núm. 1, pp. 100-105
2014
-
A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
Movement Disorders, Vol. 29, Núm. 4, pp. 470-478
-
Michael J. Fox Foundation LRRK2 Consortium: Geographical differences in returning genetic research data to study participants
Genetics in Medicine